Actively Recruiting
Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)
Led by Mastelli S.r.l · Updated on 2026-05-12
40
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
M
Mastelli S.r.l
Lead Sponsor
C
Clinical Research Technology S.r.l.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The treatment of black triangles in modern dentistry involves various approaches, both surgical and nonsurgical. Surgical methods aim to reconstruct or preserve gingival tissue using techniques such as soft tissue flaps or augmentation. Some invasive surgical methods proposed for papilla reconstruction and correction of black triangle recession include repeated interproximal curettage, Beagle's pedicle graft procedure, free epithelialized and de-epithelialized gingival grafts, and subepithelial connective tissue grafts. The success rate of surgical augmentation depends on the thickness of the gingiva biotype. Orthodontic treatment can also be used to reshape and decrease the embrasure space. An alternative option is minimally invasive procedures for tissue re-volumizing and papilla anatomical-functional reconstruction. Hyaluronic acid (HA) has been used for minimally invasive papilla reconstruction, leveraging its volumizing filler effect. Non-surgical strategies based on hyaluronan are gaining ground internationally. The immediate goal of minimally invasive treatment for interdental papilla loss and black triangle disease is mechanical protection and gingival restoration. Promoting tissue hydration, fibroblast vitality, and collagen deposition may offer a long-term regenerative medicine solution. Additionally, natural-origin, High Purification Technology Polynucleotides (PN HPTTM) are exploited for wound healing and counteracting connective tissue depletion. PNs-based medical devices are widely used in Europe and other countries for various indications, including orthopedics (intra-articular administration), dermatology (intra-dermal injections), and vulvo-vaginal application. PNs have minimal protein contaminants and allergic risks due to advanced purification techniques. Their hydrophilic nature provides hydration and acts as a volume enhancer. Recent in vitro studies demonstrate improved gingival fibroblast viability and collagen deposition with PNs. The purpose of this clinical investigation is to assess the safety and clinical performance of RDM36 in the treatment of periodontal gingival contraction and in black triangles syndrome (BTS).
CONDITIONS
Official Title
Evaluation of the Safety and Performance of the Medical Device RDM36 in the Treatment of Periodontal Gingival Contraction and in Black Triangles Syndrome (BTS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to provide written informed consent for the study
- Male or female
- Aged 18 years or older at the time of consent
- Have at least one anterior interdental papilla recession in the smile zone according to Jemt's classification (BTS)
- Teeth near the interdental papilla recession must have contact points
- No periodontal diseases
- Adequate knowledge of oral hygiene with full mouth plaque score and bleeding score values less than 10%
- No plaque or bleeding on probing at the site of interest
- No retentive factors at the site of interest
You will not qualify if you...
- Have active periodontitis
- Have an acute infection in the mouth or upper respiratory tract
- Pregnant, breastfeeding, or planning to conceive up to 120 days after treatment
- Smoke more than 10 cigarettes per day
- Have bleeding disorders or take medications affecting blood clotting
- Have systemic diseases that affect periodontal health
- Have autoimmune diseases
- Known or suspected allergy to seafood products
- Have psychiatric or behavioral disorders or substance abuse interfering with study cooperation
- Have infra-bony defects with pocket or papilla contraction visible on X-ray or probing
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Azienda Socio Sanitaria Territoriale (A.S.S.T.) degli Spedali Civili di Brescia
Brescia, Italy, Italy, 25123
Actively Recruiting
Research Team
M
Molinari
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here